Qs’ Research Institute, Otsuka Pharmaceutical Co., Ltd. Tokushima, Japan (K.M., H.S., H.A., N.A., T.K.); Otsuka Pharmaceutical Development & Commercialization, Princeton, New Jersey (R.D.M.); and Neuroscience Drug Discovery, H. Lundbeck A/S, Valby, Denmark (L.L., T.B.S., C.B., J.A.)

Qs’ Research Institute, Otsuka Pharmaceutical Co., Ltd. Tokushima, Japan (K.M., H.S., H.A., N.A., T.K.); Otsuka Pharmaceutical Development & Commercialization, Princeton, New Jersey (R.D.M.); and Neuroscience Drug Discovery, H. Lundbeck A/S, Valby, Denmark (L.L., T.B.S., C.B., J.A.)

Qs’ Research Institute, Otsuka Pharmaceutical Co., Ltd. Tokushima, Japan (K.M., H.S., H.A., N.A., T.K.); Otsuka Pharmaceutical Development & Commercialization, Princeton, New Jersey (R.D.M.); and Neuroscience Drug Discovery, H. Lundbeck A/S, Valby, Denmark (L.L., T.B.S., C.B., J.A.)

Qs’ Research Institute, Otsuka Pharmaceutical Co., Ltd. Tokushima, Japan (K.M., H.S., H.A., N.A., T.K.); Otsuka Pharmaceutical Development & Commercialization, Princeton, New Jersey (R.D.M.); and Neuroscience Drug Discovery, H. Lundbeck A/S, Valby, Denmark (L.L., T.B.S., C.B., J.A.)

Qs’ Research Institute, Otsuka Pharmaceutical Co., Ltd. Tokushima, Japan (K.M., H.S., H.A., N.A., T.K.); Otsuka Pharmaceutical Development & Commercialization, Princeton, New Jersey (R.D.M.); and Neuroscience Drug Discovery, H. Lundbeck A/S, Valby, Denmark (L.L., T.B.S., C.B., J.A.)

Qs’ Research Institute, Otsuka Pharmaceutical Co., Ltd. Tokushima, Japan (K.M., H.S., H.A., N.A., T.K.); Otsuka Pharmaceutical Development & Commercialization, Princeton, New Jersey (R.D.M.); and Neuroscience Drug Discovery, H. Lundbeck A/S, Valby, Denmark (L.L., T.B.S., C.B., J.A.)

Qs’ Research Institute, Otsuka Pharmaceutical Co., Ltd. Tokushima, Japan (K.M., H.S., H.A., N.A., T.K.); Otsuka Pharmaceutical Development & Commercialization, Princeton, New Jersey (R.D.M.); and Neuroscience Drug Discovery, H. Lundbeck A/S, Valby, Denmark (L.L., T.B.S., C.B., J.A.)

Qs’ Research Institute, Otsuka Pharmaceutical Co., Ltd. Tokushima, Japan (K.M., H.S., H.A., N.A., T.K.); Otsuka Pharmaceutical Development & Commercialization, Princeton, New Jersey (R.D.M.); and Neuroscience Drug Discovery, H. Lundbeck A/S, Valby, Denmark (L.L., T.B.S., C.B., J.A.)

Qs’ Research Institute, Otsuka Pharmaceutical Co., Ltd. Tokushima, Japan (K.M., H.S., H.A., N.A., T.K.); Otsuka Pharmaceutical Development & Commercialization, Princeton, New Jersey (R.D.M.); and Neuroscience Drug Discovery, H. Lundbeck A/S, Valby, Denmark (L.L., T.B.S., C.B., J.A.)

Qs’ Research Institute, Otsuka Pharmaceutical Co., Ltd. Tokushima, Japan (K.M., H.S., H.A., N.A., T.K.); Otsuka Pharmaceutical Development & Commercialization, Princeton, New Jersey (R.D.M.); and Neuroscience Drug Discovery, H. Lundbeck A/S, Valby, Denmark (L.L., T.B.S., C.B., J.A.)